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Postprandial changes in cardiometabolic
disease risk in young Chinese men
following isocaloric high or low protein
diets, stratified by either high or low meal
frequency - a randomized controlled
crossover trial
Alexander Mok1†, Sumanto Haldar1†, Jetty Chung-Yung Lee4, Melvin Khee-Shing Leow1,2,5
and Christiani Jeyakumar Henry1,2,3*
Abstract
Background: Cardio-Metabolic Disease (CMD) is the leading cause of death globally and particularly in Asia.
Postprandial elevation of glycaemia, insulinaemia, triglyceridaemia are associated with an increased risk of CMD.
While studies have shown that higher protein intake or increased meal frequency may benefit postprandial
metabolism, their combined effect has rarely been investigated using composite mixed meals. We therefore
examined the combined effects of increasing meal frequency (2-large vs 6-smaller meals), with high or low-protein
(40 % vs 10 % energy from protein respectively) isocaloric mixed meals on a range of postprandial CMD risk
markers.
Methods: In a randomized crossover study, 10 healthy Chinese males (Age: 29 ± 7 years; BMI: 21.9 ± 1.7 kg/m2)
underwent 4 dietary treatments: CON-2 (2 large Low-Protein meals), CON-6 (6 Small Low-Protein meals), PRO-2 (2 Large
High-Protein meals) and PRO-6 (6 Small High-Protein meals). Subjects wore a continuous glucose monitor (CGM) and
venous blood samples were obtained at baseline and at regular intervals for 8.5 h to monitor postprandial changes in
glucose, insulin, triglycerides and high sensitivity C-reactive protein (hsCRP). Blood pressure was measured at
regular intervals pre- and post- meal consumption. Urine was collected to measure excretion of creatinine and
F2-isoprostanes and its metabolites over the 8.5 h postprandial period.
Results: The high-protein meals, irrespective of meal frequency were beneficial for glycaemic health since glucose
incremental area under the curve (iAUC) for PRO-2 (185 ± 166 mmol.min.L−1) and PRO-6 (214 ± 188 mmol.min.L−1)
were 66 and 60 % lower respectively (both p < 0.05), compared with CON-2 (536 ± 290 mmol.min.L−1). The iAUC
for insulin was the lowest for PRO-6 (13.7 ± 7.1 U.min.L−1) as compared with CON-2 (28.4 ± 15.6 U.min.L−1), p < 0.001.
There were no significant differences in postprandial responses in other measurements between the dietary treatments.
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Conclusions: The consumption of composite meals with higher protein content, irrespective of meal frequency appears
to be beneficial for postprandial glycemic and insulinemic responses in young, healthy Chinese males. Implications of
this study may be useful in the Asian context where the consumption of high glycemic index, carbohydrate meals is
prevalent.
Trial registration: NCT02529228.
Keywords: High protein, Meal frequency, Cardiometabolic disease risk
Background
Increases in postprandial glucose, insulin and lipids
have been linked to increased cardiometabolic disease
(CMD) risk [1–3], even though the majority of epi-
demiological and intervention trials have relied on
measuring these parameters in the fasted state. Given
that most individuals spend majority of their waking
hours in the postprandial state, eating and digesting
food, fasting measurements alone may not, in its en-
tirety, represent the metabolic processes indicative of
CMD risk [4]. Moreover, Asians are at a greater risk
of CMD than other populations such as the Cauca-
sians [5] and several studies reported Asians having
higher levels of fasting and postprandial glucose and
insulin responses [6, 7], higher levels of HbA1C [8]
and increased type 2 diabetes risk compared with
Caucasians [9, 10]. Asians also have a lower metabolic
capacity than Caucasians to handle an excess dietary
load [11]. Therefore alterations in meal composition
and patterns are warranted in order to improve post-
prandial metabolism amongst Asians.
Increasing meal frequency has long been suggested
by several authors to improve metabolic health and
weight control [12–14]. It has been shown that eating
smaller and frequent meals seems to better maintain
blood glucose, blood lipid and incretin hormone con-
centrations, with lower variations throughout the day
[14, 15]. However, the evidence thus far relating to
the effects of meal frequency alone on glycaemic
response remain equivocal with some studies showing
a greater postprandial glucose responses with in-
creased meal frequency [16, 17], while other studies
reporting lower blood glucose responses with higher
meal frequencies in non-diabetics [14] as well in dia-
betics [18, 19]. There have also been studies reporting
no difference in postprandial glycaemia with increased
meal frequency [20, 21]. However, the compositions
of the meals were rather heterogenous between these
studies and this may explain the disparate findings
observed between studies investigating the effect of
meal frequency alone.
It is widely known that Asian diets are particularly rich
in refined carbohydrates which may exacerbate the risk
of type 2 diabetes and CVD [22]. A recent review has
highlighted that the prevalence of diabetes worldwide
also parallels the increases in carbohydrate intake over
the same period [23]. Therefore, modulating dietary
carbohydrate content and composition has been sug-
gested to be an effective way of decreasing glycaemia
[24, 25]. Recent evidence suggests that consuming
higher amounts of protein can lead to a lower CMD risk
[26–29]. In particular, greater protein to carbohydrate
ratios in the diet have been shown result in better gly-
caemic control [29–32].
Therefore the primary aim of this study was to investigate
whether altering protein composition with or without in-
creasing meal frequency can improve postprandial glucose
and/or insulin response in young, healthy, Chinese males.
Since postprandial glycemic control is also associated with
changes in triglyceride, hs-CRP and markers of oxidative
stress [2], as secondary outcomes, we have also measured
postprandial changes in these markers in plasma as a result
of the acute dietary modulations.
Methods
Participants
This randomized control trial was conducted at the Clinical
Nutrition Research Centre (CNRC) within the Singapore
Institute of Clinical Sciences (SICS), Agency of Science
Technology and Research (A*STAR), Singapore, between
October 2014 to July 2015. The study received ethical
approval from the Domain Specific Review Board of the
National Healthcare Group in Singapore (NHG DSRB Ref-
erence No. 2014/01054). All subjects gave their written in-
formed consent before participating in the study.
Research procedures and trial protocols were followed
in accordance to good clinical practice (GCP) guide-
lines and with the ethical standards in concordance to
the Declaration of Helsinki, 1983. This trial is regis-
tered within clinicaltrials.gov under trial registration
no. NCT02529228.
Healthy Chinese males between the ages of 21–40 years
were recruited for this trial. The exclusion criteria for
the study were: 1) smokers, 2) BMI > 25 kg/m2; 3) fasting
blood glucose > 5.5 mmol/l; 4) blood pressure > 130/
90 mmHg; 5) body weight change > 3 kg within the pre-
vious 2 months; 6) having taken part in any dietary
intervention trials or having followed a special dietary
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habit (e.g., vegetarian, Atkins, weight reducing diets)
within 3 months of study participation; 7) suffering from
any endocrine (thyroid dysfunction) or metabolic (dys-
lipidemia, diabetes, metabolic syndrome) disorders; and
8) alcohol use > 4 days per week. Volunteers who met
the initial inclusion/exclusion criteria at screening were
invited to take part in the study. A total of 10 volunteers
were recruited and there were no withdrawals from the
study. Participant characteristics are summarized in
Table 1.
Design
The study was a randomized, crossover trial with four
acute dietary conditions, comparing postprandial effects
of varying two parameters of: 1) meal frequency and 2)
dietary protein composition, in a 2-by-2 factorial design.
Participants were studied under 4 separate 1-day isocalo-
ric nutritional interventions: CON-2 (2 large Low-
Protein meals :10 % Protein, 57 % Carbohydrate, 38 %
Fat); CON-6 (6 Small Low-Protein meals with identical
nutrient composition as CON-2); PRO-2 (2 Large High-
Protein meals :38 % Protein, 30 % Carbohydrate, 32 %
Fat); PRO-6 (6 Small High-Protein meals with identical
nutrient composition as PRO-2). The order of the ses-
sions was randomized with a washout period of at least
3 days between interventions. Participants refrained
from alcohol consumption and vigorous exercise 48-h
before each trial session. The evening before each session,
participants came to the clinical suite for the insertion of a
continuous glucose monitor (CGM) (Medtronics, USA)
under the abdominal subcutaneous adipose tissue by a
trained researcher and also for the consumption of a stan-
dardized evening meal. Participants fasted for 12-h follow-
ing their evening meal up to the start of each session. The
CGM measured interstitial glucose levels in 5 min inter-
vals for the entire duration of the sessions.
Study protocol
The schematic of the study protocol is shown in Fig. 1.
On the morning of each test day, the participants arrived
in a fasting state. Throughout each test session, lasting
8.5 h during the day (0800–1630 h), participants stayed
within a clinical suite and predominantly remained in a
seated posture doing passive work (i.e., watching TV,
using computers or reading quietly). The temperature of
the suite was kept under thermo-neutral conditions (air-
conditioned to keep within 22–24 degree Celsius ((°C))
throughout the entire study period. At the start of each
test day, an indwelling venous cannula was inserted into
the participant’s antecubital vein by a trained nurse for
the collection of baseline and subsequent regular blood
sampling. This cannula was kept patent by flushing with
3 ml non-heparinized saline. After the fasting baseline
blood sample was taken, participants consumed high or
low protein isocaloric mixed meals in either a 2-meal or
6-meal frequency pattern over the subsequent 8.5 h
period. The total energy content of the meals (approxi-
mately 2000 kcals) were designed to provide a small cal-
oric surplus based on two-thirds (from breakfast and
lunch) of the daily energy requirements for an average
sedentary male (Singapore National Nutrition Survey,
2010) [33]. This would reflect the typical overconsump-
tion of calories in modern day society. For the 2-meal
trials (CON-2 and PRO-2), test meals consisted of 1
large breakfast meal and 1 large lunch meal, whereas for
the 6-meal trials (CON-6 and PRO-6), the breakfast and
lunch were each divided into 3 equal, isocaloricl por-
tions. Meal times were scheduled at equidistant time
points (Fig. 1); that is, during the 2-meal sessions, meals
were provided at 4.5-h intervals (0800 and 1230-h), and
during the 6-meal sessions, meals were served at 1.5-h
intervals (0800, 0930, 1100, 1230, 1400, and 1530). Two
of the meals during the 6-meal trials were provided at
the same time as the meals during the 2-meal conditions
(i.e., 0800 and 1230). Postprandial blood samples and
blood pressure measurements were taken at 1 to 1.5-h
intervals. Participants also collected their entire urine
passed during the 8.5-h postprandial period for the ana-
lyses of urinary F2-isoprostanes, its metabolites and cre-
atinine excretion.
The energy and the macronutrient compositions, along
with the food amounts and constituents and the estimated
glycemic indices (GIs) of the test meals are detailed in
Table 2. The estimated GIs of each composite meal were
calculated according to the method by Hatonen KA et al.
[34]. The GI of individual foods used for the study were
derived using published GI data of foods same or similar
foods [35, 36]. Based on these calculations for the low-
protein CON-2/CON-6 meals, the overall GI was esti-
mated to be 62, whereas, for the high-protein PRO-2/
PRO-6 meals, the overall GI was estimated to be 31. Vol-
unteers were required to consume all of their meals as
provided and no other food or drinks were permitted.
Researcher surveillance of study participants during meal
Table 1 Participant’s characteristics
Range
Characteristic Mean (SD) Min Max
Age (Years) 28.8 (6.6) 22 40
Height (m) 1.76 (0.04) 1.71 1.84
Body Mass (kg) 68.2 (7.8) 58.1 83
Body Mass Index (kg/m2) 21.9 (1.7) 19.5 24.5
Umbilical Waist Circumference (cm) 80.5 (7.9) 70 92
Body Fat % 17.0 (4.7) 8.9 22.6
Systolic Blood Pressure (mmHg) 120.4 (5.7) 113 130
Diastolic Blood Pressure (mmHg) 76.1 (6.4) 65 85
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times and collection of empty food containers ensured
dietary compliance. Participants were asked to consume
each meal within 15-mins of serving. There were no com-
plaints of any gastrointestinal or other discomforts after
consuming the test meals. Plain drinking water was pro-
vided ad libitum during first test day and this volume was
consumed for the remaining test sessions. All blood sam-
ples were collected in K-EDTA blood vacutainer tubes
(Becton Dickinson Diagnostics, USA) and were centri-
fuged at 4500 rpm for 10 mins at 4 °C. The plasma so
obtained was immediately stored at −80 °C until batch
analysis of separate analytes at the completion of the clin-
ical trial. Subcutaneous interstitial fluid glucose readings
were obtained every 5-min for the entire 8.5 h postpran-
dial period using the CGM. Appropriate calibrations with
capillary blood glucose were also made for this purpose.
Plasma samples were assayed for insulin, triacylglycerol
(TAG), and high-sensitivity C-reactive protein (hs-CRP)
using an immunochemistry analyzer COBAS e411 (Roche,
HITACHI, USA). Urinary F2-Isoprostanes (5-F2t-iso-
prostane and 15-F2t-isoprostane) and its metabolites
(2,3-dinor-15-F2t-isoprostane and 2,3-dinor-5,6-dihy-
dro-15-F2t-isoprostane) were measured using a LC-MS/
MS method [37, 38] and creatinine was measured using
the COBAS e411 analyser (Roche, Hitachi, USA).
Standard 
Dinner
Large Meal
Small Meals
8am
4.30pm
0-hr 1 2.5 4 5.5 7 8.5-hr
12-hr fast
12.30pm
= Venous blood sample using a cannula, preceded by  
blood pressure (BP) measurement
Day Before Trial Day
= Insertion of Continuous Glucose Monitor (CGM)  
CGM
CGM
Large Meal
Small Meals
Fig. 1 Study Protocol: For each dietary condition, participants came to the clinical trial facilities on 2 consecutive days. The day before the main
trial day was for the insertion of a continuous glucose monitor and the consumption of a standardized evening meal. On the main trial day, BP
and venous blood samples were collected at regular intervals, as shown, for up to 8.5 h following the first meal of each dietary condition
Table 2 Nutritional information of test-meals
CON-2, CON-6 dietary conditions
Meal Constituents: Breakfast – White Bread (171 g), Margarine (30 g),
Malted Cocoa Drink (375 g)
Lunch – Chicken Soup Noodles (225 g), Cashew Nuts (30 g)
Breakfast Lunch Total
Energy (kcal) 889 1127 2016
Protein (g) 23 g (10 %) 26 g (9 %) 49 (10 %)
Carbohydrate (g) 130 g (57 %) 134 g (42 %) 264 (52 %)
Fat (g) 32 g (33 %) 53 g (49 %) 85 (38 %)
Estimated Glycaemic Index 73.4 50.3 61.7
PRO-2, PRO-6 dietary conditions
Meal Constituents: Breakfast – Milk (300 g), Ice-Cream (150 g), Whey
powder (91.2 g), Cashew Nuts (30 g), Lunch – Braised Chicken (330 g),
Prawn Dumplings (120 g), Malted Cocoa Drink (375 g)
Breakfast Lunch Total
Energy (kcal) 910 998 1908
Protein (g) 89 g (39 %) 90 g (36 %) 179 (38 %)
Carbohydrate (g) 66 g (30 %) 75 g (31 %) 141 (30 %)
Fat (g) 31 g (31 %) 37 (33 %) 68 (32 %)
Estimated Glycaemic Index 37.1 24.9 30.6
Macronutrient information obtained from nutrition labels on constituent foods
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Statistical analyses
The initial sample size was calculated to detect a difference
between dietary conditions in the primary outcome mea-
sures, being both postprandial glycemia and insulinemia,
using primary data obtained from a similar dietary inter-
vention by Holmstrup M et al. [17]. A sample size of 9 was
estimated to detect a difference with a 80 % power and a
significance (α) level set at 0.05 using a crossover design.
The incremental area under the curve (iAUC) for postpran-
dial CGMS glucose, plasma insulin, triglycerides and hs-
CRP as well as blood pressure (BP) were calculated using
the trapezoidal method [39] and compared between dietary
treatments using a one-way ANOVA. The concentrations
of glucose, insulin, TAG, hsCRP and BP were compared be-
tween treatments and over time using two-way repeated
measures ANOVA. Where appropriate, Bonferroni post
hoc comparisons were used. Data are presented as means
(standard deviations, SD) unless otherwise defined. Signifi-
cance was set at p < 0.05. Statistical analyses were carried
out using Statistical Package for the Social Sciences statis-
tical software, version 23.0 (IBM Inc.).
Results
Figure 2 displays the 8.5 h postprandial response,
depicted as mean incremental areas under the curve
(iAUCs) for glucose, insulin, triacylglycerol (TAG), sys-
tolic and diastolic blood pressure for each of the 4 diet-
ary conditions. One-way repeated measures ANOVA for
the mean iAUCs showed significant differences overall,
between the dietary treatments for glucose (P = .003,
η2 = .399), insulin (P = .001, η2 = .433) and TAG (P = .026,
η2 = .287). Table 3 summarizes the pairwise comparisons
of the means between dietary conditions across time as
well as the differences in the iAUCs for each dietary treat-
ment and their respective effect size (d) as compared with
CON-2.
Postprandial glucose, insulin and triglycerides
For CGMS gluclose, the iAUCs for PRO 2 and PRO 6
were significantly lower than that of both CON 2 and
CON 6 (all P < 0.05) when compared using least signifi-
cant differences. The glucose iAUCs for CON-6, PRO-2
and PRO-6 were 11, 66 and 60 % lower respectively, as
compared to CON-2. For plasma insulin, the iAUC for
PRO 2 and PRO 6 were significantly lower than CON 2
(P < 0.05) when compared using least significant differ-
ences. The insulin iAUC for CON-6, PRO-2 and PRO-6
were 30, 36 and 52 % lower respectively, compared to
CON-2. For plasma TAG, the iAUC for CON-6 was
24 % lower respectively compared to the CON-2 trial.
The iAUC for PRO-2 and PRO-6 were slightly higher
(10 and 16 % respectively), compared to the CON-2 al-
though these differences were not statistically significant.
Postprandial hs-CRP, blood pressure
Plasma hs-CRP levels were measured at 0, 1, 4, 5.5 and
8.5-h to obtain an indication of differences in postpran-
dial inflammatory response between the dietary condi-
tions. No statistical significant differences were found.
These time points for measurements were selected based
on the highest and the lowest fluctuations of the glucose
measurements (CGM data) from baseline in order to
assess whether postprandial glycaemic variation was as-
sociated with changes in hs-CRP levels. There were also
no significant differences in systolic or diastolic blood
pressure between different dietary conditions.
Urinary total F2-isoprostanes and creatinine excretion
The mean total urinary excretions of 5-F2t-isoprostane,
the sum of 15-F2t-isoprostane metabolites (2,3-dinor-15-
F2t-isoprostane and 2,3-dinor-5,6-dihydro-15-F2t-isopros-
tane) and creatinine over the entire 8.5 h postprandial
period for each dietary condition is shown in Table 4. Sur-
prisingly, 15-F2t-isoprostane (parent compound) being the
well-noted biomarker of oxidative stress in vivo [40] was
found in trace amounts or not detectable in the urine
samples of the subjects. Urinary creatinine excretion of
15-F2t-isoprostane metabolites during PRO-2 and PRO-6
were significantly higher than CON-2 (p < 0.05). There
being differences in creatinine excretion between the dif-
ferent dietary conditions, excretion of F2-isoprostanes or
its metabolites could not be adjusted for creatinine excre-
tion. We did not find any statistical difference between
5-F2t-isoprostane between the different dietary condi-
tions, although the sum of 15-F2t-isoprostane metabo-
lites were significantly higher in PRO-2 and PRO-6
than CON-2 (p < 0.05).
Discussion
To our best knowledge, this is first study to have investi-
gated the combined effects of increasing meal frequency
and/or protein composition on range of postprandial car-
diometabolic markers in an Asian population. Moreover,
in most studies investigating influence of high or low pro-
tein with/without changes in meal frequency on postpran-
dial metabolic responses used either supplemental meal
replacement powders or liquid diets [17, 41–43], whereas,
we have used mixed-composite meals which are better
representation of a regular diet. This is also the first study
using the continuous glucose monitoring (CGM) to deter-
mine the combined effects of increased meal frequency
with or without higher protein content to determine PPG
response. This having collected glucose data every 5 min
over the 8.5 h postprandial period should be more accur-
ate than using capillary/venous glucose samples, which
are generally collected at greater sampling intervals.
From the previous literature, it appears though that the
beneficial effects of increasing meal frequency in
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improving PPG might be more relevant in those with
impaired glucose tolerance (IGT) and diabetes than in
healthy individuals [18–21]. In our study we have also
demonstrated that increasing meal frequency per se did
not have a major influence on postprandial glucose
control. However, as expected, increasing protein con-
tent of the meals (from 10 % of energy to ~40 % of en-
ergy) led to significant reductions in PPG by about
60 %, as well as maintained it within 0.5 mmol/l of
baseline, irrespective of changes in meal frequency.
This was likely to be due to the lower glycemic index
(GI) as well as the lower glycemic load (GL) of the
high-protein (PRO-2/PRO-6) meals, as compared to the
low-protein (CON-2/CON-6) meals. Therefore for the
first time, we have been able to show that the GI/GL of
the diet seems more important in controlling PPG irre-
spective of meal frequency. Increased dietary protein
intake have been shown to reduce postprandial gly-
caemic response in several studies both acutely [44, 45]
and chronically [32]. On the other hand, postprandial
insulinaemic (PPI) responses were lower with increas-
ing meal frequency, independently of meal compos-
ition. For example, CON-6 dietary condition had
approximately 30 % lower postprandial iAUC of insulin
compared with CON-2 dietary condition, whereas,
PRO-6 dietary condition had 24 % lower iAUC com-
pared with PRO-2 and these may be physiologically
relevant. Similar observations of lower postprandial
Fig. 2 Postprandial responses over time (left); Incremental Areas Under the Curve (Right). Error bars are standard error of the mean (SEM)
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insulin response with increasing meal frequency have also
been observed by several other investigators [16, 18, 21].
Moreover, the combined effects of higher protein intake
with increased meal frequency gave rise to the lowest
iAUC for postprandial insulin compared with the three
other dietary conditions. While it is well known that diet-
ary protein is insulinogenic [46], in this study we have
shown that when the same quantity and quality of protein
in diet is separated into smaller boluses through increas-
ing meal frequency (PRO-6), the total PPI response was
much lower than having the same meal as larger boluses
(PRO-2). At the same time, we did not find any major dif-
ference in the postprandial glycaemic response between
PRO-2 and PRO-6 dietary conditions, which may indir-
ectly indicate that the insulin sensitivity in conditions of
high protein and high meal frequency (PRO-6) might be
greater than PRO-2. Although insulin sensitivity was not
directly tested in our study, similar observations were
made in other longer term studies, where a moderate in-
take of 20–25 % protein had given rise to better insulin
sensitivity than a higher dietary protein (25–30 % protein
as energy) intake [47]. It should also be noted that differ-
ent protein types (e.g., whey, casein, soy) can give rise to
variability in postprandial insulinaemic response [45] and
this has to be taken into consideration before arriving at
any meaningful conclusion regarding dietary protein
Table 3 Postprandial responses across time
Time (h) 0 1 2.5 4 5.5 7 8.5 iAUC Overall p
(Diet)
D
Glucose (mmol/L)
CON-2 4.7 ± 0.6 6.1 ± 1.1a 5.4 ± 0.6a 4.8 ± 0.8a 6.8 ± 1.0a 5.7 ± 0.5 5.4 ± 0.8 536 ± 290 .003
CON-6 5.0 ± 0.8 6.2 ± 1.1 5.9 ± 0.5b 5.8 ± 0.6b 6.1 ± 0.5a 5.7 ± 0.7a 6.1 ± 1.1 480 ± 292 - 0.19
PRO-2 4.8 ± 0.4 5.2 ± 0.4b 5.0 ± 0.4a 4.9 ± 0.4a 5.2 ± 0.6b 5.2 ± 0.7 5.0 ± 0.8 185 ± 166 - 1.21
PRO-6 4.7 ± 0.4 5.2 ± 0.4 5.0 ± 0.4a 5.1 ± 0.4a 5.1 ± 0.5b 5.1 ± 0.6b 5.2 ± 0.7 214 ± 188 - 1.11
Insulin (μU/ml)
CON-2 6.1 ± 3.3 84.3 ± 45.3a 74.0 ± 43.6a 21.6 ± 16.8 105.6 ± 61.0a 62.0 ± 46.4 28.6 ± 17.9 28.4 ± 15.6 a .001
CON-6 8.1 ± 5.0 49.7 ± 19.5 60.1 ± 31.9 45.6 ± 29.2a 53.7 ± 33.2 39.5 ± 22.0 44.8 ± 24.9 19.8 ± 10.3 - 0.57
PRO-2 6.0 ± 4.2 63.3 ± 41.2 58.7 ± 36.2 25.6 ± 18.5b 46.6 ± 22.5 34.4 ± 24.9 27.8 ± 25.9 18.1 ± 10.6 - 0.68
PRO-6 7.1 ± 3.6 47.6 ± 28.4b 39.4 ± 21.3b 30.8 ± 16.3 34.6 ± 12.6b 28.3 ± 15.4 36.0 ± 25.0 13.7 ± 7.1b - 0.97
TAG (mmol/L)
CON-2 0.9 ± 0.3 1.2 ± 0.4 1.6 ± 0.6 1.5 ± 0.6 1.6 ± 0.5 1.4 ± 0.6 1.6 ± 0.4 294 ± 133 .026
CON-6 1.1 ± 0.5 1.1 ± 0.5 1.4 ± 0.5 1.6 ± 0.6 1.6 ± 0.6 1.6 ± 0.5 1.8 ± 0.6 224 ± 139 - 0.52
PRO-2 0.9 ± 0.3 1.1 ± 0.3 1.6 ± 0.6 1.5 ± 0.4 1.7 ± 0.6 1.7 ± 0.5 1.7 ± 0.6 322 ± 91 0.21
PRO-6 1.0 ± 0.5 1.2 ± 0.5 1.6 ± 0.6 1.9 ± 0.8 1.9 ± 0.7 1.9 ± 0.7 2.0 ± 0.7 340 ± 175 0.34
hs-CRP (mg/L)
CON-2 0.74 ± 1.41 0.79 ± 1.44 - 0.74 ± 1.44 0.69 ± 1.39 - 0.72 ± 1.40 −0.5 ± 90 .17
CON-6 0.80 ± 1.04 0.81 ± 1.00 - 0.73 ± 0.87 0.66 ± 0.81 - 0.55 ± 0.70 −50 ± 115 - 0.55
PRO-2 0.64 ± 0.86 0.69 ± 0.84 - 0.70 ± 0.82 0.65 ± 0.77 - 0.63 ± 0.71 12 ± 71 0.14
PRO-6 0.12 ± 0.18 0.13 ± 0.21 - 0.15 ± 0.23 0.18 ± 0.24 - 0.17 ± 0.25 19 ± 35 0.22
Systolic BP (mmHg)
CON-2 120 ± 10 122 ± 10 121 ± 11 120 ± 7 118 ± 8 123 ± 9 122 ± 9 459 ± 3343 .84
CON-6 118 ± 6 120 ± 6 118 ± 9 116 ± 6 121 ± 8 120 ± 6 120 ± 6 249 ± 2101 −0.06
PRO-2 116 ± 8 123 ± 8 118 ± 11 118 ± 12 120 ± 13 116 ± 6 119 ± 8 1501 ± 4658 0.31
PRO-6 119 ± 8 119 ± 7 118 ± 12 120 ± 9 120 ± 7 118 ± 11 123 ± 9 245 ± 4209 −0.06
Diastolic BP (mmHg)
CON-2 78 ± 8 73 ± 8 76 ± 9 78 ± 7 71 ± 8 73 ± 8 77 ± 5 −1560 ± 2399 .86
CON-6 76 ± 6 76 ± 9 74 ± 7 73 ± 6 73 ± 4 76 ± 7 75 ± 6 −614 ± 2272 −0.39
PRO-2 78 ± 9 75 ± 5 74 ± 7 75 ± 9 77 ± 14 72 ± 8 77 ± 8 −1466 ± 3024 −0.04
PRO-6 79 ± 6 77 ± 10 76 ± 6 76 ± 6 76 ± 8 76 ± 8 77 ± 6 −1473 ± 2642 −0.04
All values are mean ± standard deviation. n = 10. iAUC: Incremental Area under the Curve for 8.5 h period. D: Effect size Cohen’s d, Glass’sΔ correction. Figures with
differing superscript letters are significantly different: p <0.05 (after Bonferroni correction)
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content and insulin sensitivity. Postprandial hypertrigly-
ceridaemia is associated with increased CVD and type 2
diabetes risk [48, 49]. Therefore the 24 % lower mean
iAUC of postprandial triglyceridaemia (TAG) with in-
creasing meal frequency in the low protein-high carbohy-
drate (CON-6) condition as compared with CON-2
condition is likely to be physiologically relevant, even
though this was not statistically significant due to the large
inter-individual variability.
Given that the postprandial state is also associated
with an increased oxidative stress and/or inflammation
[48, 50], we investigated whether high and low protein
diets, in combination with high and low meal frequency
patterns can modify markers of postprandial oxidative
stress or inflammation. We did not find any significant
influence of altering meal frequency per se on these pa-
rameters and these findings are similar to other studies
where no differences in oxidative stress markers upon
changing meal frequency were observed [51]. However,
we found that while the excretion 15-F2t-isoprostane
metabolites (2,3-dinor-15-F2t-isoprostane and 2,3-dinor-
5,6-dihydro-15-F2t-isoprostane) increased with higher
protein intake (PRO-2 and PRO-6 combined vs CON-2
and CON-6 combined, p < 0.05), the excretion of 5-F2t-
isoprostane was in fact lower with higher protein intakes
(74 and 59 % lower in PRO-2 and PRO-6 diets respect-
ively as compared to the CON-2 diet), although none of
these differences were statistically significant. It should
be noted that the urine samples of the subjects in this
study had only trace concentrations of 15-F2t-isopros-
tane compared to 5-F2t-isoprostane; similar findings
were reported in other studies [52]. This, in addition to
the increased renal clearance, as evidenced by greater
creatinine excretion with higher protein diets, explained
the higher excretion of 15-F2t-isoprostane metabolites in
PRO-2 and PRO-6 diets compared with the low protein
(CON-2 and CON-6) diets. We have also compared the
ratios of F2-isoprostane to creatinine excretion for the
separate of F2-isoprostane species between the different
dietary conditions, although there were no statistical dif-
ferences. Thus, increased excretion of 15-F2t-isoprostane
metabolites in this study with increased protein intake
may not necessarily indicate increased oxidative stress
with the higher protein diets, particularly given that the
5-F2t-isoprostane excretion was much lower and that 5-
F2t-isoprostane could well be better marker of in vivo
oxidative stress under some circumstances [53]. The
higher creatinine excretion with increasing protein in-
take (PRO-2 and PRO-6 vs CON-2 and CON-6) was
similar to other observations which could be due to a
higher glomerular filtration rate [54, 55]. However, in
healthy volunteers without any kidney disorder, there is
no evidence to show that having a high protein diet is
detrimental to kidney health [56, 57]. While there are
some indications that dietary carbohydrate load is asso-
ciated with increased CRP levels [58], we did not find
any effect of varying meal composition in our study on
postprandial hsCRP levels. While postprandial hsCRP
levels was unaltered with the acute dietary modulations,
it remains to be investigated how similar dietary
changes may affect hsCRP in the longer term. Finally,
one of the major limitations of the study was that the
postprandial responses were tested after dietary ma-
nipulation for one day only. How longer term dietary
manipulations will affect these responses remain to be
investigated.
Conclusions
In contrast to previous studies that have used meal
replacement liquid based formulas to undertake similar
investigations, we have for the first time demonstrated
that it is feasible to use solid composite mixed meals to
study combined effect of high protein content and
increased meal frequency on markers of postprandial
cardiometabolic risk. As expected, we found that in-
creasing protein content of meals decreased PPG re-
sponse. Contrary to the commonly held view that
increasing meal frequency attenuates postprandial gly-
caemia, our results seem to indicate that the overall pro-
tein content and the consequent glycemic index and/or
glycemic load of the meals may be more important than
meal frequency alone. There were some indications that
increasing meal frequency may benefit postprandial
insulinemia. Increasing meal frequency and/or protein
composition did not affect the other postprandial
markers of cardiometabolic risk measured in this study.
However, these remain to be tested in larger populations
using longer term trials. The findings of this study will
have important implications in Asians who already con-
sume diets rich in carbohydrates with high glycaemic
index. In order to improve their cardiometabolic risk,
Asians may increase the protein content of the meal, ir-
respective of any need to change their meal frequency.
Table 4 Total Urinary Excretions of 5-F2t-isoprostanes, 15-F2t-isoprostanes Metabolites and Creatinine over 8.5 h postprandial period
CON-2 Mean (SD) CON-6 Mean (SD) PRO-2 Mean (SD) PRO-6 Mean (SD) Overall p (ANOVA)
5-F2t-isoprostanes (μg) 7.8 (13.84) 3.4 (3.96) 2.0 (2.20) 3.2 (4.94) 0.268
Sum of 15-F2t-isoprostane metabolites (μg) 2.4 (1.50) 3.2 (2.89) 4.7 (2.53) 3.4 (1.48) 0.059
Creatinine (mmol) 4.2 (1.0) 5.8 (1.8) 8.4 (4.7) 7.6 (2.8) 0.004
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